After reviewing existing published literature, the agency initiated the approval of Wellcovorin — which GSK stopped selling ...
The drug, iberdomide, is one of a few protein-degrading medicines the company hopes to become successors to its blockbuster ...
The clearance of Keytruda QLEX follows similar approvals for Bristol Myers and Roche. Elsewhere, MBX’s parathyroidism drug ...
The collapse in value of many biotechs over the past few years has created an opportunity for specialists like Xoma to “do ...
The denial sets back a drug Scholar Rock hopes to become part of a new standard of care for spinal muscular atrophy, treatment for which has changed dramatically over the last decade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback